Semaglutides FDA Approval to Treat MASH By inducing weight loss and improving metabolic health, semaglutide can decrease toxicity from fat accumulation and liver cell damage, allowing the liver to heal and achieve fibrosis regression, says Naim Alkhouri, MD, hepatologist and chief medical officer at Summit Clinical Research in San Antonio
The origin of CAFs remains unclear, and some propose that they derive from the activation of resident fibroblast [98, 99], from recruited bone marrow progenitors [100], or the transdifferentiation from endothelial [101, 102] or epithelial to mesenchymal [103]
Blood pressure, blood sugar, and cholesterol levels all tend to improve with weight loss, and overall, these medications have benefits in terms of lowering the risk of cardiovascular disease, says Dr
Prescribers are required to retain a completed and signed copy of the PA form